Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Aptevo Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for APVO.
You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.
Other companies in Aptevo Therapeutics’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Connect Biopharma Hldgs (NASDAQ:CNTB), Imunon (NASDAQ:IMNN), Burning Rock Biotech (NASDAQ:BNR) and Cyclacel Pharmaceuticals (NASDAQ:CYCC).
Aptevo Therapeutics has a consensus price target of $8.00.
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $4.535 last updated May 28, 2025 at 11:37 AM EDT.
There are no upcoming dividends for Aptevo Therapeutics.
Aptevo Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.
There is no upcoming split for Aptevo Therapeutics.
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.